Metropolitan Life Insurance Company (MetLife)’s Xperi XPER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,730
Closed -$32.9K 2141
2024
Q1
$32.9K Hold
2,730
﹤0.01% 1614
2023
Q4
$30.1K Hold
2,730
﹤0.01% 1721
2023
Q3
$26.9K Buy
2,730
+520
+24% +$6.15K ﹤0.01% 1744
2023
Q2
$29.1K Sell
2,210
-504
-19% -$5.46K ﹤0.01% 1727
2023
Q1
$29.7K Hold
2,714
﹤0.01% 1691
2022
Q4
$23.4K Buy
+2,714
New +$31.1K ﹤0.01% 1929

Other funds holding XPER

Metropolitan Life Insurance Company (MetLife)'s XPER Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Xperi (XPER) in Q2 2024, closing a stake of 2,730 shares — an estimated $32.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in XPER in Q4 2022 and held it in 6 quarters. The position peaked at $32.9K in Q1 2024. 154 funds tracked by Wall St. Rank hold XPER as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Xperi position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,730 Xperi shares in Q2 2024, an estimated $32.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Xperi in Q4 2022 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Xperi position peaked at $32.9K in Q1 2024.
  • 154 funds tracked by Wall St. Rank held Xperi as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.